AKT1 and type 2 diabetes mellitus: Worthy of note is that Gal-1 is considered a new fibrotic promoter protein in type 1 and type 2 diabetes [1], whose production is activated by the AP4 transcription factor through AKT pathway and is translated in excess deposition of the extracellular matrix (ECM).